Dong-A Socio Holdings Co.,Ltd
Founded 1949, KOSPI-listed 1970, Dong-A Socio Holdings makes Bacchus and pharma/non-pharma goods, allied with Meiji Seika on biosimilars.
As of 2026-10-10, Dong-A Socio Holdings Co.,Ltd has 8 Korean MFDS device approvals, 160 Korean MFDS drug approvals, 19 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).
Price
Change
Market cap
Business overview
Source: DART corporate disclosureDong-A Socio Holdings Co.,Ltd was established in 1949 and listed on the KOSPI market in 1970 as a holding company overseeing business units organized into six reporting segments. It manufactures and sells pharmaceuticals such as the fatigue-recovery drink Bacchus and hospital pharmaceuticals, along with non-pharmaceutical products including medical devices, hair dyes, and mouthwash, as well as cosmetics. It has a comprehensive business alliance agreement with Meiji Seika Pharma of Japan, running from September 2011 to September 2031, for joint research, development, production, and sales of biosimilars.
Products & technology
- BacchusFatigue-recovery drink (pharmaceutical)
- Hospital pharmaceuticalsPharmaceuticals
- Medical devicesNon-pharmaceutical
- Hair dyeNon-pharmaceutical
- MouthwashNon-pharmaceutical
- CosmeticsCosmetics manufacturing and wholesale/retail
Regulatory approvals
data.go.kr160 Korean MFDS drug approvals · 1966–2026 / 8 Korean MFDS device approvals · 2014–2026
- MFDSSubsidiary: 동아제약Dressing, fluid-impermeable film2026-08-24Product approval · Class 2제인 26-4783 호
- MFDS drugSubsidiary: 동아제약Luna OneQ syr.2026-07-14Drug · OTC · Notification202602034
- MFDS drugSubsidiary: 동아제약Pydialrenew Cream2026-06-19Drug · OTC · Notification202601740
- MFDSSubsidiary: 동아제약material, denture, adhesive2026-05-20Product approval · Class 2제인 26-4449 호
- MFDS drugSubsidiary: 동아제약ChamTopy Soft Cap.2026-04-14Drug · OTC · Notification202601082
- MFDS drugSubsidiary: 동아제약Dong-A Bismuth Subsalicylate oral suspension2026-02-26Drug · OTC · Approval202600587
- MFDS drugSubsidiary: 동아제약Aclean vita gel2025-12-29Drug · OTC · Notification202503405
- MFDS drugSubsidiary: 동아제약Panpyrin Time Dayflu dry syrup2025-12-22Drug · OTC · Notification202503342
- MFDS drugSubsidiary: 동아제약Panpyrin Time Powder2025-10-28Drug · OTC · Notification202502770
- MFDS drugSubsidiary: 동아제약Dong-A Pharm. Algy-OneQ Soft Cap.2025-10-24Drug · OTC · Notification202502742
- MFDS drugSubsidiary: 동아제약Panpyrin Time Ibu Cough syrup2025-10-01Drug · OTC · Notification202502602
- MFDS drugSubsidiary: 동아제약Panpyrin Time Ibu Cold syrup2025-10-01Drug · OTC · Notification202502603
Show 68 more
- MFDS drugSubsidiary: 동아제약Pantec Time Powder2025-09-17Drug · OTC · Notification202502468
- MFDS drugSubsidiary: 동아제약Panpyrin Time Ibu Nose Syrup2025-09-12Drug · OTC · Notification202502420
- MFDS drugSubsidiary: 동아제약Pojidual Cream2025-08-26Drug · OTC · Notification202502219
- MFDS drugSubsidiary: 동아제약Melavita tab.2025-08-22Drug · OTC · Notification202502187
- MFDS drugSubsidiary: 동아제약Panpyrin Time Nightflu dry syrup2025-08-06Drug · OTC · Notification202502047
- MFDS drugSubsidiary: 동아제약PANTEC TIME dry syrupRevoked2025-07-31Drug · OTC · Notification202501997
- MFDS drugSubsidiary: 동아제약Panpyrin Night Sol.2025-07-02Drug · OTC · Notification202501643
- MFDS drugSubsidiary: 동아제약Benachio Pro Sol.2025-06-19Drug · OTC · Notification202501523
- MFDS drugSubsidiary: 동아제약Dong-A Pharm. Ginkgo Soft Cap. 120mg2025-06-12Drug · OTC · Notification202501443
- MFDS drugSubsidiary: 동아제약Noscardin Gel2025-06-09Drug · OTC · Notification202501407
- MFDS drugSubsidiary: 동아제약CHAMQVITA2025-05-30Drug · OTC · Notification202501352
- MFDS drugSubsidiary: 동아제약Benachio Pro Sol.Revoked2025-04-30Drug · OTC · Notification202501062
- MFDS drugSubsidiary: 동아제약Benachio M Sol.2025-04-28Drug · OTC · Notification202501018
- MFDS drugSubsidiary: 동아제약Pantec Time Night syrup2025-03-31Drug · OTC · Notification202500745
- MFDS drugSubsidiary: 동아제약Pantec Time Cough syrup2025-03-31Drug · OTC · Notification202500746
- MFDS drugSubsidiary: 동아제약Pantec Time Cold syrup2025-03-18Drug · OTC · Notification202500612
- MFDS drugSubsidiary: 동아제약LUNAVITA Tab.2025-03-17Drug · OTC · Notification202500585
- MFDS drugSubsidiary: 동아제약Magrang B Pidol-Shot Sol.2025-03-06Drug · OTC · Notification202500514
- MFDS drugSubsidiary: 동아제약Eye Jokul Renew PDRN Eye drops 1.0%(single use)2025-01-23Drug · OTC · Notification202500181
- MFDS drugSubsidiary: 동아제약PANTEC A Tab.2025-01-03Drug · OTC · Notification202500018
- MFDS drugSubsidiary: 동아제약PANTEC A Sol.2024-12-09Drug · OTC · Notification202402898
- MFDS drugSubsidiary: 동아제약PANTEC Cold Syrup2024-10-29Drug · OTC · Notification202402551
- MFDS drugSubsidiary: 동아제약Donga Acetaminophen powder 160mg(Acetaminophen)2024-10-15Drug · OTC · Notification202402430
- MFDS drugSubsidiary: 동아제약ACET One-Q powder 500mg(Acetaminophen)2024-10-15Drug · OTC · Notification202402431
- MFDS drugSubsidiary: 동아제약MemoZen Tab. 240mg2024-10-14Drug · OTC · Notification202402428
- MFDS drugSubsidiary: 동아제약D Pancure Cream2024-10-11Drug · OTC · Notification202402414
- MFDS drugSubsidiary: 동아제약Capillus Foam Aerosols (Minoxidil)2024-08-08Drug · OTC · Notification202401930
- MFDS drugSubsidiary: 동아제약Tathion Tab. 100mg2024-07-11Drug · OTC · Notification202401710
- MFDS drugSubsidiary: 동아제약Champ Cold Pen High Syrup2024-05-23Drug · OTC · Notification202401275
- MFDS drugSubsidiary: 동아제약Ibu400 OneQ S Soft Cap. (Ibuprofen)2024-04-02Drug · OTC · Notification202400730
- MFDS drugSubsidiary: 동아제약D Panbug Gel2024-03-19Drug · OTC · Notification202400576
- MFDS drugSubsidiary: 동아제약Magrang B Pidolax Soft Cap.2024-02-08Drug · OTC · Notification202400300
- MFDS drugSubsidiary: 동아제약Benachio EZ Sol.2024-01-17Drug · OTC · Notification202400115
- MFDS drugSubsidiary: 동아제약Eye Jokul Pro Eye drops (Trehalose Hydrate) (single use)2024-01-09Drug · OTC · Notification202400066
- MFDS drugSubsidiary: 동아제약Champ Cough S liquid2024-01-05Drug · OTC · Notification202400039
- MFDS drugSubsidiary: 동아제약Ganact Sol.2023-11-29Drug · OTC · Notification202303237
- MFDS drugSubsidiary: 동아제약Panpyrin C Sol.2023-11-27Drug · OTC · Notification202303219
- MFDS drugSubsidiary: 동아제약Panpyrin-A Sol.2023-11-22Drug · OTC · Notification202303193
- MFDS drugSubsidiary: 동아제약Max Chondroitin 1200 oral gel2023-11-20Drug · OTC · Approval202303174
- MFDS drugSubsidiary: 동아제약Champ Cold Pen Syrup2023-11-15Drug · OTC · Notification202303142
- MFDS drugSubsidiary: 동아제약Eye Jokul Soo Eye drops 0.5%(single use)2023-10-30Drug · OTC · Notification202303024
- MFDS drugSubsidiary: 동아제약Eye Jokul Soo Eye drops 1.0%(single use)2023-10-30Drug · OTC · Notification202303025
- MFDS drugSubsidiary: 동아제약Dioline T Powder for Oral Suspension(Diosmin)2023-07-18Drug · OTC · Approval202302177
- MFDSSubsidiary: 동아제약Irrigation unit, vaginal2023-06-30Product approval · Class 2제허 23-739 호
- MFDS drugSubsidiary: 동아제약Easyquil Night Liquid2023-06-13Drug · OTC · Approval202301813
- MFDS drugSubsidiary: 동아제약Benachio S Sol.2023-05-11Drug · OTC · Notification202301521
- MFDS drugSubsidiary: 동아제약Dong-A Pharm Kyungokgo2023-03-31Drug · OTC · Notification202301096
- MFDS drugSubsidiary: 동아제약Champ Clod Syrup2022-11-28Drug · OTC · Notification202204272
- MFDS drugSubsidiary: 동아제약ACLEAN gel2022-11-21Drug · OTC · Approval202204171
- MFDSSubsidiary: 동아제약material, denture, adhesive2022-07-27Product approval · Class 2제인 22-4559 호
- MFDS drugSubsidiary: 동아제약PlexB Dualcare Tab.2022-07-18Drug · OTC · Notification202202956
- MFDS drugSubsidiary: 동아제약Dioline Tab. 600mg(Diosmin)2022-04-29Drug · OTC · Notification202201755
- MFDSSubsidiary: 동아제약Dressing, fluid-impermeable filmRevoked2022-04-12Product approval · Class 2제인 22-4287 호
- MFDS drugSubsidiary: 동아제약Magrang B Soft Cap.2022-02-25Drug · OTC · Notification202200864
- MFDS drugSubsidiary: 동아제약Benachio Kids Sol.2022-02-08Drug · OTC · Notification202200604
- MFDS drugSubsidiary: 동아제약PlexB Plus Tab.2022-01-11Drug · OTC · Notification202200204
- MFDS drugSubsidiary: 동아제약Champ Aller-non Sol.2021-12-09Drug · OTC · Notification202107872
- MFDS drugSubsidiary: 동아제약Dong- A Pharm. Cal-Ma Vita-F Sol.2021-11-24Drug · OTC · Notification202107607
- MFDS drugSubsidiary: 동아제약Champu Nebulizer2021-10-28Drug · OTC · Notification202107173
- MFDS drugSubsidiary: 동아제약Dong-A Pharm. Balamin-Mi Liquid2021-10-26Drug · OTC · Notification202107134
- MFDS drugSubsidiary: 동아제약Pantec-Q Plus Soft Cap.2021-10-21Drug · OTC · Notification202107058
- MFDS drugSubsidiary: 동아제약Pantec-Q Nose Plus Soft Cap.2021-10-21Drug · OTC · Notification202107059
- MFDS drugSubsidiary: 동아제약Pantec-Q Cough Plus Soft Cap.2021-10-21Drug · OTC · Notification202107060
- MFDS drugSubsidiary: 동아제약Dong-A Pharm. Ferum Multi Vita Tab.2021-10-19Drug · OTC · Notification202107007
- MFDS drugSubsidiary: 동아제약Dong-A Pharm. Balamin Z Tab.2021-10-08Drug · OTC · Notification202106837
- MFDS drugSubsidiary: 동아제약Dong-A Pharm. Balamin SyrupRevoked2021-09-29Drug · OTC · Notification202106677
- MFDS drugSubsidiary: 동아제약Dong-A Pharm. Mag n Vita SyrupRevoked2021-07-05Drug · OTC · Notification202105064
- MFDS drugSubsidiary: 동아제약Chiomax Ointment2021-06-23Drug · OTC · Notification202104809
Showing the 80 most recent of 168 records.
Global clinical trials
ClinicalTrials.gov · sponsor-matched- Subsidiary: 동아제약Evaluate the Efficacy and Safety of Hydrolyzed Keratin Peptide Powder on Hair Health
Completed · 2024-01 · NCT07458828
- Subsidiary: 동아제약Effect of DA-5515 (Circulan® Soft Cap.) in Patients With Chronic Fatigue Symptoms Due to Impaired Blood Circulation
Phase 4 · Unknown · 2018-01 · NCT03542721
- Subsidiary: 동아제약Effect of a Liquid Toothpaste on Periodontal Disease
Completed · 2014-08 · NCT03117153
- Subsidiary: 동아제약Pharmacokinetic/Pharmacodynamic & Safety Study of G3041 and SEVIKAR® Tablet in Healthy Adult Volunteers
Phase 1 · Unknown · 2013-12 · NCT02058472
- Subsidiary: 동아제약Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Udenafil and Dapoxetine
Phase 1 · Unknown · 2013-09 · NCT01928563
- Subsidiary: 동아제약Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Udenafil and Bosentan After Oral Administration
Phase 1 · Unknown · 2013-08 · NCT01929213
- Subsidiary: 동아제약Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of DA-1229 and Metformin After Oral Administration in Healthy Male Subjects
Phase 1 · Completed · 2013-07 · NCT01941199
- Subsidiary: 동아제약Clinical Trial to Evaluate the Efficacy and Safety of DA-8031 in Male Patients With Premature Ejaculation
Phase 2 · Unknown · 2013-01 · NCT01798667
Phase 1 · Completed · 2012-07 · NCT01776047
Phase 4 · Completed · 2012-03 · NCT01719575
Show 12 more trials
Phase 3 · Completed · 2012-02 · NCT01718119
- Subsidiary: 동아제약Study of SI000413 in Knee Osteoarthritis Patients
Phase 2 · Unknown · 2012-01 · NCT01525758
Phase 4 · Completed · 2011-12 · NCT01922375
Phase 3 · Completed · 2011-11 · NCT01901640
Phase 3 · Completed · 2011-04 · NCT01774864
- Subsidiary: 동아제약A Study to Evaluate the Efficacy and Safety of DA-6034 and to Demonstrate the Non-inferiority of DA-6034
Phase 3 · Unknown · 2010-10 · NCT01813812
Phase 1 · Completed · 2010-07 · NCT01156779
- Subsidiary: 동아제약A Study to Evaluate the Safety of DA-3030 and to Explore the Efficacy for Diabetic Neuropathic Pain
Phase 1 · Completed · 2010-06 · NCT01820715
- Subsidiary: 동아제약A Study to Evaluate the Tolerability, Safety and Pharmacokinetic Characteristics of DA-3803
Phase 1 · Completed · 2010-05 · NCT01851512
Phase 1 · Completed · 2010-05 · NCT01104948
- Subsidiary: 동아제약A Study to Characterize the Pharmacokinetics/Pharmacodynamics and Effect of Food of DA-1229 in Healthy Male Subjects
Phase 1 · Unknown · 2009-05 · NCT00961025
- Subsidiary: 동아제약A Pharmacokinetic Study of Udenafil in Adult Subjects With or Without Impaired Hepatic Function
Phase 1 · Completed · 2007-11 · NCT00956306
Key disclosures
KRX KIND via OpenDARTShow 14 more events
Publications
PubMed · affiliation-matched- Engineering of long-acting human growth hormone-Fc fusion proteins: Effects of valency, fusion position, and linker design on pharmacokinetics and efficacy.
PloS one · 2025-01 · Lee T, Lee D, Jung E 외 3
- Gender differences and dose proportionality in the toxicokinetics of udenafil and its active metabolite following oral administration in rodents.
Toxicology and applied pharmacology · 2021-01 · Lee JH, Lee DY, Kang KK 외 3
- Pathological manifestation of the induced pluripotent stem cell-derived cortical neurons from an early-onset Alzheimer's disease patient carrying a presenilin-1 mutation (S170F).
Cell proliferation · 2020-04 · Li L, Kim HJ, Roh JH 외 11
- Quality by Design approaches to assessing the robustness of tangential flow filtration for MAb.
Biologicals : journal of the International Association of Biological Standardization · 2020-01 · Wee H, Koo K, Bae E 외 1
- Efficacy of evogliptin and cenicriviroc against nonalcoholic steatohepatitis in mice: a comparative study.
The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2019-11 · Wang Z, Park H, Bae EJ
- The First Generation of iPSC Line from a Korean Alzheimer's Disease Patient Carrying APP-V715M Mutation Exhibits a Distinct Mitochondrial Dysfunction.
Experimental neurobiology · 2019-06 · Li L, Roh JH, Kim HJ 외 9
- Additive effects of evogliptin in combination with pioglitazone on fasting glucose control through direct and indirect hepatic effects in diabetic mice.
European journal of pharmacology · 2018-07 · Kim TH, Lee JH, Chae YN 외 2
- MerTK mediates STAT3-KRAS/SRC-signaling axis for glioma stem cell maintenance.
Artificial cells, nanomedicine, and biotechnology · 2018-01 · Eom H, Kaushik N, Yoo KC 외 6
- Absorption, metabolism, and excretion of [14C]evogliptin tartrate in male rats and dogs.
Journal of toxicology and environmental health. Part A · 2018-01 · Lee DY, Kim JH, Shim HJ 외 2
- Comparison of biosimilar filgrastim with a reference product: pharmacokinetics, pharmacodynamics, and safety profiles in healthy volunteers.
Drug design, development and therapy · 2018-01 · Choi C, Yoo BW, Kim CO 외 5
Show 9 more publications
- Unique binding mode of Evogliptin with human dipeptidyl peptidase IV.
Biochemical and biophysical research communications · 2017-12 · Lee HK, Kim MK, Kim HD 외 5
- In vitro evaluation of potential transporter-mediated drug interactions of evogliptin.
Biopharmaceutics & drug disposition · 2017-09 · Lee DY, Chae HW, Shim HJ
- Effect of transmembrane pressure on Factor VIII yield in ATF perfusion culture for the production of recombinant human Factor VIII co-expressed with von Willebrand factor.
Cytotechnology · 2016-10 · Kim SC, An S, Kim HK 외 3
- Corrigendum to "Induced neural stem cells from distinct genetic backgrounds exhibit different reprogramming status" [Stem Cell Res. 16(2) (2016) 460-468].
Stem cell research · 2016-07 · Kim SM, Lim KT, Kwak TH 외 14
- Modified harvest system for enhancing Factor VIII yield in alternating tangential flow perfusion culture.
Journal of bioscience and bioengineering · 2016-05 · Kim SC, An S, Kim HK 외 3
- Induced neural stem cells from distinct genetic backgrounds exhibit different reprogramming status.
Stem cell research · 2016-03 · Kim SM, Lim KT, Kwak TH 외 14
- The effects of a single intravenous injection of novel activin A/BMP-2 (AB204) on toxicity and the respiratory and central nervous systems.
Drug and chemical toxicology · 2016-01 · Yoon BH, Lee JH, Na K 외 7
- Pharmacokinetics, Pharmacodynamics, and Efficacy of a Novel Long-Acting Human Growth Hormone: Fc Fusion Protein.
Molecular pharmaceutics · 2015-10 · Kim SJ, Kwak HH, Cho SY 외 6
- The toxicological evaluation of repetitive 2- and 4-week intravenous injection of Activin A/BMP-2 chimera (AB204) into rats.
Regulatory toxicology and pharmacology : RTP · 2015-10 · Yoon BH, Lee JH, Na K 외 2
Patents
KIPRIS · applicant-matched- Subsidiary: 동아제약천연 추출물로서 테르펜 또는 테르페노이드 성분 함유하는 것을 특징으로 하는 항균 또는 항진균용 조성물
Published · 2024-12 · Application 1020240195590
PCT · Published · 2024-12 · Application PCT/IB2024/062866
- Subsidiary: 동아제약CONTROLLED-RELEASE FORMULATION FOR ORAL ADMINISTRATION COMPRISING MELATONIN, AND PREPARATION METHOD THEREFOR
PCT · Published · 2024-09 · Application PCT/IB2024/058622
PCT · Published · 2024-09 · Application PCT/KR2024/013177
PCT · Published · 2024-08 · Application PCT/IB2024/058380
EP · Published · 2024-02 · Application 24759836.0
- Subsidiary: 동아제약COMPOSITION COMPRISING PH-SENSITIVE LIPID NANOPARTICLES CONTAINING CATIONIC MATERIAL
US · Published · 2023-12 · Application 19141413
- Subsidiary: 동아제약COMPOSITION COMPRISING PH-SENSITIVE LIPID NANOPARTICLES CONTAINING CATIONIC MATERIAL
PCT · Published · 2023-12 · Application PCT/KR2023/021496
- Subsidiary: 동아제약구미 젤리용 조성물 및 이를 이용한 구미 젤리 제조 방법
Published · 2023-12 · Application 1020230186692
- Subsidiary: 동아제약카페인을 포함하는 방출조절용 제제 및 이의 제조방법
Published · 2023-12 · Application 1020230185770
Show 426 more patents
- Subsidiary: 동아제약멜라토닌을 포함하는 방출조절 경구투여용 제제 및 이의 제조방법
Published · 2023-11 · Application 1020230169970
- Subsidiary: 동아제약반려동물 섭식 기호도가 향상된 면역기능성 사료첨가제 조성물
Registered · 2023-10 · Application 1020230148529
Registered · 2023-09 · Application 1020230126816
- Subsidiary: 동아제약필름 코팅용 조성물 및 이를 포함하는 필름 코팅액
Registered · 2023-05 · Application 1020230067967
- Subsidiary: 동아제약애엽 추출물을 포함하는 피부 손상 개선용 조성물
Withdrawn · 2023-02 · Application 1020230021255
- Subsidiary: 동아제약양이온성 물질을 포함하는 pH 감응형 지질나노입자를 포함하는 조성물
Registered · 2022-12 · Application 1020220183584
- Subsidiary: 동아제약티아민 또는 그의 유도체와 피돌산 마그네슘을 포함하는 경구용 조성물 및 복합 제제
Registered · 2022-11 · Application 1020220145104
PCT · Published · 2022-09 · Application PCT/KR2022/013421
PCT · Published · 2022-09 · Application PCT/KR2022/013422
- Subsidiary: 동아제약리도카인 또는 이의 약학적으로 허용가능한 염 및 글리세린모노스테아레이트를 포함하는 치질치료용 약학적 조성물
Rejected · 2021-12 · Application 1020210187760
- Subsidiary: 동아제약신규한 락토바실러스 파라카제이 균주 및 이의 용도
Registered · 2021-12 · Application 1020210174925
- Subsidiary: 동아제약3D 프린팅을 이용한 젤리 조성물의 안정화 방법
Published · 2021-11 · Application 1020210168360
- Subsidiary: 동아제약비피더스 유산균 생장촉진 및 장내 유해균 클로스트리듐 디피실리균 억제 효능을 갖는 장 건강 균주 락토바실러스 파라카제이 EPS DA-BACS 및 그 다당류
Registered · 2021-09 · Application 1020210121920
- Subsidiary: 동아제약락토바실러스 유산균 생장촉진 효능을 갖는 장 건강 균주 비피도박테리움 비피덤 EPS DA-LAIM 및 그 다당류
Registered · 2021-09 · Application 1020210121265
- Subsidiary: 동아제약천연 추출물로서 테르펜 또는 테르페노이드 성분 함유하는 것을 특징으로 하는 항균 또는 항진균용 조성물
Rejected · 2021-09 · Application 1020210118677
- Subsidiary: 동아제약레코플라본 또는 이의 염을 포함하는 피부개선용 화장료 조성물
Registered · 2021-07 · Application 1020210098144
US · Registered · 2020-12 · Application 17138534
US · Registered · 2020-12 · Application 17138309
- Subsidiary: 동아제약적층 방식으로 제조된 방출 조절용 약제학적 조성물
Registered · 2020-12 · Application 1020200183425
- Subsidiary: 동아제약애엽 추출물을 포함하는 피부 손상 개선용 조성물
Registered · 2020-10 · Application 1020200134700
- Subsidiary: 동아제약소독용 겔 조성물 및 이의 제조 방법
Registered · 2020-09 · Application 1020200127595
- Subsidiary: 동아제약비스테로이드성 소염진통 활성성분을 함유하는 필름 형성 약제학적 조성물
Withdrawn · 2019-12 · Application 1020190174578
- Subsidiary: 동아제약IBUPROFEN SUSPENSION COMPOSITION AND DOSAGE FORM
PCT · Published · 2019-07 · Application PCT/KR2019/008375
- Subsidiary: 동아제약동충하초 농축액을 유효성분으로 포함하는 여성 갱년기 증상 예방 또는 치료용 조성물
Registered · 2019-05 · Application 1020190062648
- Subsidiary: 동아제약FILM-FORMING PHARMACEUTICAL COMPOSITION CONTAINING NONSTEROIDAL ANTI-INFLAMMATORY ANALGESIC ACTIVE INGREDIENT
PCT · Published · 2019-02 · Application PCT/KR2019/001891
US · Registered · 2018-09 · Application 16141044
- Subsidiary: 동아제약이부프로펜의 현탁액 조성물 및 투여 제형
Registered · 2018-08 · Application 1020180095051
- Subsidiary: 동아제약강황추출물 및 쌀눈대두 발효추출물을 포함하는 간보호용 조성물
Registered · 2018-04 · Application 1020180049915
TW · Registered · 2018-03 · Application 107111157
US · Published · 2018-03 · Application 16498633
EP · Registered · 2018-03 · Application 18775644.0
PCT · Published · 2018-03 · Application PCT/JP2018/013559
Registered · 2018-03 · Application 1020197028836
- Subsidiary: 동아제약비스테로이드성 소염진통 활성성분을 함유하는 필름 형성 약제학적 조성물
Withdrawn · 2018-02 · Application 1020180021128
US · Registered · 2017-10 · Application 16341005
EP · Registered · 2017-10 · Application 17788041.6
PCT · Published · 2017-10 · Application PCT/US2017/055793
- Subsidiary: 동아제약가용화 비사코딜의 대장선택방출형 경구용 고형제제
Withdrawn · 2017-07 · Application 1020170095689
- Subsidiary: 동아제약흉터치료를 위한 국소용 약학적 조성물
Expired · 2017-03 · Application 1020170042182
- Subsidiary: 동아제약셀프 스캐너, 그 셀프 스캐너를 이용한 피로도 측정 시스템 및 방법
Rejected · 2016-12 · Application 1020160175612
- Subsidiary: 동아제약COMPOSITION FOR TREATING DRY EYE SYNDROME, CONTAINING BOG BILBERRY EXTRACT AS ACTIVE INGREDIENT
PCT · Published · 2016-12 · Application PCT/KR2016/014935
CN · Published · 2016-08 · Application 201680062207.9
US · Registered · 2016-08 · Application 15253773
EP · Registered · 2016-08 · Application 16842297.0
PCT · Published · 2016-08 · Application PCT/KR2016/009743
Registered · 2016-08 · Application 1020187008806
US · Published · 2016-08 · Application 15246721
- Subsidiary: 동아제약TRANSDERMAL PREPARATION CONTAINING ANTIFUNGAL ACTIVE MATERIAL
EP · Published · 2016-04 · Application 16780326.1
- Subsidiary: 동아제약TRANSDERMAL PREPARATION CONTAINING ANTIFUNGAL ACTIVE MATERIAL
PCT · Published · 2016-04 · Application PCT/KR2016/003952
- Subsidiary: 동아제약케라틴 조직의 진균감염증 치료를 위한 약제학적 조성물
Registered · 2016-03 · Application 1020160028730
- Subsidiary: 동아제약PHARMACEUTICAL COMPOSITION FOR TREATING FUNGAL INFECTIOUS DISEASES OF KETRATIN TISSUE
PCT · Published · 2016-03 · Application PCT/KR2016/002415
CN · Published · 2015-10 · Application 201580061545.6
US · Registered · 2015-10 · Application 14923525
PCT · Published · 2015-10 · Application PCT/KR2015/011386
TW · Published · 2015-06 · Application 104118604
US · Published · 2015-06 · Application 15317538
EP · Published · 2015-06 · Application 15807343.7
PCT · Published · 2015-06 · Application PCT/JP2015/066136
Withdrawn · 2015-06 · Application 1020167030439
- Subsidiary: 동아제약항진균성 활성물질을 포함하는 경피 제제
Registered · 2015-04 · Application 1020150054524
TW · Published · 2014-10 · Application 103135675
PCT · Published · 2014-10 · Application PCT/JP2014/076898
US · Registered · 2014-10 · Application 14506025
- Subsidiary: 동아제약내산성 및 안정성이 향상된 프로바이오틱스 코팅 고체 조성물의 제조 방법
Registered · 2014-09 · Application 1020140116947
- Subsidiary: 동아제약히드로퀴논을 포함하는 저자극성 피부 미백용 조성물
Registered · 2014-07 · Application 1020140096292
- Subsidiary: 동아제약항염 및 살균력이 증진된 치주질환 예방 또는 개선용 조성물
Registered · 2014-07 · Application 1020140086980
CN · Published · 2014-05 · Application 201480030403
US · Registered · 2014-05 · Application 14893813
EP · Published · 2014-05 · Application 14803672.6
PCT · Published · 2014-05 · Application PCT/KR2014/004858
- Subsidiary: 동아제약Film-forming pharmaceutical composition for wound healing and method for preparing the same
CN · Published · 2014-02 · Application 201480008377
- Subsidiary: 동아제약Film-forming pharmaceutical composition for wound healing and method for preparing the same
US · Registered · 2014-02 · Application 14765318
- Subsidiary: 동아제약FILM-FORMING PHARMACEUTICAL COMPOSITION FOR WOUND HEALING AND METHOD FOR PREPARING THE SAME
EP · Registered · 2014-02 · Application 14751188.5
- Subsidiary: 동아제약FILM-FORMING PHARMACEUTICAL COMPOSITION FOR WOUND HEALING AND METHOD FOR PREPARING THE SAME
PCT · Published · 2014-02 · Application PCT/KR2014/001103
PCT · Published · 2013-06 · Application PCT/KR2013/005266
Expired · 2013-05 · Application 1020130062413
- Subsidiary: 동아제약상처 치료용 필름형성 약제학적 조성물 및 그의 제조방법
Registered · 2013-02 · Application 1020130015400
Registered · 2013-01 · Application 1020130009164
Registered · 2012-06 · Application 1020120068646
- Subsidiary: 동아제약신규한 위식도역류질환 치료용 조성물
Registered · 2012-06 · Application 1020120064222
Withdrawn · 2011-12 · Application 1020110134515
Withdrawn · 2011-11 · Application 1020110121150
Expired · 2011-08 · Application 1020110080326
Withdrawn · 2011-04 · Application 1020110034213
- Subsidiary: 동아제약위식도 역류질환 치료용 액상 타입 조성물
Withdrawn · 2011-03 · Application 1020110025860
Registered · 2011-01 · Application 1020110007326
Registered · 2010-12 · Application 1020100137450
Registered · 2010-11 · Application 1020100117354
Registered · 2010-11 · Application 1020100117355
Registered · 2010-09 · Application 1020100094109
- Subsidiary: 동아제약활성 약물을 함유하는 하이드로콜로이드
Registered · 2010-08 · Application 1020100079669
Expired · 2010-04 · Application 1020100038039
US · Published · 2010-03 · Application 13259699
EP · Published · 2010-03 · Application 13175341.0
EP · Registered · 2010-03 · Application 10759016.8
- Subsidiary: 동아제약IMPROVED METHOD FOR MANUFACTURING DIPEPTIDYL PEPTIDASE-IV INHIBITOR AND INTERMEDIATE
EP · Published · 2010-03 · Application 10759017.6
Registered · 2010-03 · Application 1020100028477
Registered · 2010-03 · Application 1020100028476
Expired · 2010-03 · Application 1020100026863
Expired · 2010-03 · Application 1020100026484
Registered · 2009-12 · Application 1020090119006
Withdrawn · 2009-11 · Application 1020090116241
Expired · 2009-11 · Application 1020090108284
Registered · 2009-10 · Application 1020090103823
PCT · Published · 2009-10 · Application PCT/KR2009/005970
Expired · 2009-09 · Application 1020090085614
TW · Published · 2009-07 · Application 098125853
PCT · Published · 2009-07 · Application PCT/KR2009/004188
Rejected · 2009-07 · Application 1020090063996
Expired · 2009-02 · Application 1020090013350
Expired · 2009-02 · Application 1020090012733
Expired · 2008-12 · Application 1020080128499
- Subsidiary: 동아제약NOVEL 1,3-DIHYDRO-5-ISOBENZOFURANCARBONITRILE DERIVATIVES AND PHARMACEUTICAL COMPOSITION THEREOF FOR THE TREATMENT OF PREMATURE EJACULATION
EP · Published · 2008-10 · Application 08846179.3
- Subsidiary: 동아제약NOVEL 1,3-DIHYDRO-5-ISOBENZOFURANCARBONITRILE DERIVATIVES AND PHARMACEUTICAL COMPOSITION THEREOF FOR THE TREATMENT OF PREMATURE EJACULATION
PCT · Published · 2008-10 · Application PCT/KR2008/006445
Expired · 2008-10 · Application 1020080105439
Expired · 2008-10 · Application 1020080103808
Withdrawn · 2008-10 · Application 1020080101911
Registered · 2008-10 · Application 1020080101932
Registered · 2008-09 · Application 1020080094529
Rejected · 2008-09 · Application 1020080085718
Rejected · 2008-07 · Application 1020080074462
Registered · 2008-07 · Application 1020080068893
Registered · 2008-06 · Application 1020080059420
- Subsidiary: 동아제약PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CHRONIC HEART FAILURE COMPRISING PYRAZOLOPYRIMIDINONE DERIVATIVE COMPOUND
US · Published · 2008-06 · Application 12602847
- Subsidiary: 동아제약PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CHRONIC HEART FAILURE COMPRISING PYRAZOLOPYRIMIDINONE DERIVATIVE COMPOUND
EP · Registered · 2008-06 · Application 08766063.5
- Subsidiary: 동아제약PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CHRONIC HEART FAILURE COMPRISING PYRAZOLOPYRIMIDINONE DERIVATIVE COMPOUND
PCT · Published · 2008-06 · Application PCT/KR2008/003101
- Subsidiary: 동아제약A BIODEGRADABLE MICROSPHERE COMPOSITION SUITABLE FOR THE CONTROLLED RELEASE OF GLUCOSE CONTROLLING PEPTIDE AND FORMULATION THEREOF
EP · Published · 2008-04 · Application 08741460.3
Registered · 2008-04 · Application 1020080036052
Expired · 2008-04 · Application 1020080036189
Rejected · 2008-03 · Application 1020080021695
Registered · 2008-03 · Application 1020080019764
Registered · 2008-02 · Application 1020080019179
Registered · 2008-02 · Application 1020080017768
- Subsidiary: 동아제약개선된 피부 저류 및 발모 효과를 갖는 미녹시딜 함유조성물
Registered · 2008-02 · Application 1020080013707
Registered · 2008-02 · Application 1020080013673
Withdrawn · 2008-01 · Application 1020080009786
Rejected · 2007-12 · Application 1020070138166
Registered · 2007-09 · Application 1020070096790
Withdrawn · 2007-09 · Application 1020070096662
Rejected · 2007-08 · Application 1020070088593
Registered · 2007-06 · Application 1020070056392
Registered · 2007-06 · Application 1020070055427
Rejected · 2007-06 · Application 1020070054283
Expired · 2007-04 · Application 1020070033398
Expired · 2007-03 · Application 1020070025952
Registered · 2007-02 · Application 1020070019560
EP · Published · 2006-12 · Application 06824078.7
EP · Registered · 2006-11 · Application 06812660.6
Expired · 2006-11 · Application 1020060113721
Expired · 2006-10 · Application 1020060105684
Expired · 2006-09 · Application 1020060090367
EP · Registered · 2006-08 · Application 06783600.7
PCT · Published · 2006-08 · Application PCT/KR2006/003181
Expired · 2006-08 · Application 1020060076619
Withdrawn · 2006-07 · Application 1020060066440
Rejected · 2006-05 · Application 1020060042937
Rejected · 2006-05 · Application 1020060040534
- Subsidiary: 동아제약AGENT FOR THE PREVENTION AND TREATMENT OF PROSTATIC HYPERPLASIA COMPRISING PYRAZOLOPYRIMIDINONE COMPOUND
PCT · Published · 2006-04 · Application PCT/KR2006/001242
Expired · 2006-04 · Application 1020060030724
Expired · 2006-03 · Application 1020060028087
Rejected · 2006-02 · Application 1020060019590
Withdrawn · 2005-11 · Application 1020050112782
Expired · 2005-10 · Application 1020050101634
Expired · 2005-10 · Application 1020050101633
- Subsidiary: 동아제약Agent for the prevention and treatment of liver diseases containing pyrazolopyrimidine derivative
CN · Published · 2005-10 · Application 200580050065
- Subsidiary: 동아제약AGENT FOR THE PREVENTION AND TREATMENT OF LIVER DISEASES CONTAINING PYRAZOLOPYRIMIDINE DERIVATIVE
EP · Published · 2005-10 · Application 05808627.3
- Subsidiary: 동아제약AGENT FOR THE PREVENTION AND TREATMENT OF LIVER DISEASES CONTAINING PYRAZOLOPYRIMIDINE DERIVATIVE
PCT · Published · 2005-10 · Application PCT/KR2005/003526
Expired · 2005-10 · Application 1020050099900
Expired · 2005-10 · Application 1020050097226
Rejected · 2005-09 · Application 1020050089355
Rejected · 2005-09 · Application 1020050089356
Rejected · 2005-09 · Application 1020050089354
Expired · 2005-07 · Application 1020050059110
Expired · 2005-06 · Application 1020050054366
Expired · 2005-06 · Application 1020050049830
- Subsidiary: 동아제약AN AGENT COMPRISING FGF2 AS AN EFFECTIVE INGREDIENT FOR TREATMENT OR PREVENTION OF ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE
EP · Published · 2005-05 · Application 05764757.0
- Subsidiary: 동아제약AN AGENT COMPRISING FGF2 AS AN EFFECTIVE INGREDIENT FOR TREATMENT OR PREVENTION OF ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE
PCT · Published · 2005-05 · Application PCT/KR2005/001390
Expired · 2005-05 · Application 1020050039405
Withdrawn · 2005-02 · Application 1020050016715
- Subsidiary: 동아제약Oxazolidinone derivatives
EP · Registered · 2004-12 · Application 10183967.8
Withdrawn · 2004-10 · Application 1020040079644
- Subsidiary: 동아제약7-CARBOXYMETHYLOXY-3 , 4 , 5-TRIMETHOXY FLAVONE MONOHYD RATE, THE PREPARATION METHOD AND USES THEREOF
EP · Registered · 2004-09 · Application 04774508.8
EP · Published · 2004-09 · Application 08019101.8
- Subsidiary: 동아제약7-CARBOXYMETHYLOXY-3`, 4`, 5-TRIMETHOXY FLAVONE MONOHYDRATE, THE PREPARATION METHOD AND USES THEREOF
PCT · Published · 2004-09 · Application PCT/KR2004/002247
Expired · 2004-09 · Application 1020057016164
Expired · 2004-07 · Application 1020040058809
Expired · 2004-07 · Application 1020040051766
Expired · 2004-04 · Application 1020040023664
Expired · 2004-04 · Application 1020040023663
Rejected · 2003-11 · Application 1020030079776
Withdrawn · 2003-10 · Application 1020030071925
Withdrawn · 2003-09 · Application 1020030061938
Withdrawn · 2003-08 · Application 1020030057593
PCT · Published · 2003-07 · Application PCT/KR2003/001502
Expired · 2003-07 · Application 1020030051574
Expired · 2003-07 · Application 1020030046548
Expired · 2003-05 · Application 1020030033116
Rejected · 2003-05 · Application 1020030031227
Expired · 2003-05 · Application 1020030029437
Expired · 2003-03 · Application 1020030016539
Expired · 2002-11 · Application 1020020068496
Expired · 2002-10 · Application 1020020063970
Expired · 2002-04 · Application 1020020022007
Expired · 2002-01 · Application 1020020002651
Expired · 2001-11 · Application 1020010069476
Expired · 2001-09 · Application 2020010028884
Expired · 2001-08 · Application 1020010052416
Expired · 2001-08 · Application 1020010051528
Expired · 2001-07 · Application 1020010045321
Expired · 2001-07 · Application 1020010045318
Expired · 2001-07 · Application 1020010045317
Expired · 2001-07 · Application 1020010045319
Expired · 2001-07 · Application 1020010045320
Expired · 2001-07 · Application 1020010042196
- Subsidiary: 동아제약A PROCESS FOR PREPARING PYRAZOLOPYRIMIDINONE DERIVATIVES FOR THE TREATMENT OF IMPOTENCE
EP · Registered · 2001-05 · Application 01932366.6
EP · Published · 2001-05 · Application 01932368.2
Expired · 2001-04 · Application 1020010022132
Expired · 2001-03 · Application 1020010015118
Expired · 2001-03 · Application 1020010011691
Withdrawn · 2001-03 · Application 1020010011690
Withdrawn · 2000-09 · Application 1020000057572
Expired · 2000-09 · Application 1020000056035
Expired · 2000-08 · Application 1020000046445
Expired · 2000-08 · Application 1020000046446
Withdrawn · 2000-08 · Application 1020000046224
Expired · 2000-07 · Application 1020000038332
Expired · 2000-06 · Application 1020000035817
Expired · 2000-06 · Application 1020000034966
Expired · 2000-06 · Application 1020000030896
Expired · 2000-05 · Application 1020000026805
Withdrawn · 2000-04 · Application 1020000021137
Expired · 2000-02 · Application 1020000004835
Expired · 2000-02 · Application 1020000004836
- Subsidiary: 동아제약COMPOSITIONS CONTAINING ITRACONAZOLE WITH IMPROVED BIOAVAILABILITY AND NARROW INTRA- AND INTER-INDIVIDUAL VARIATION OF ITS ABSORPTION
EP · Published · 1999-12 · Application 99962555.1
Expired · 1999-12 · Application 1019990059466
Expired · 1999-12 · Application 1019990058878
Expired · 1999-12 · Application 1019990057803
Expired · 1999-12 · Application 1019990055802
Expired · 1999-11 · Application 1019990052090
- Subsidiary: 동아제약PYRAZOLOPYRIMIDINONE DERIVATIVES FOR THE TREATMENT OF IMPOTENCE
EP · Registered · 1999-11 · Application 99954478.6
Expired · 1999-11 · Application 1019990049384
Expired · 1999-09 · Application 1019990041205
Expired · 1999-09 · Application 1019990037463
Expired · 1999-08 · Application 1019990035029
Rejected · 1999-07 · Application 1019990026370
Expired · 1999-05 · Application 1019990016129
Rejected · 1999-01 · Application 1019990002148
Expired · 1999-01 · Application 1019990001149
Expired · 1999-01 · Application 1019990001150
- Subsidiary: 동아제약Gastroprotective flavone/flavanone compounds with therapeutic effect on inflammatory bowel disease
US · Registered · 1999-01 · Application 09214889
Expired · 1998-12 · Application 1019980052483
Expired · 1998-11 · Application 1019980048781
Rejected · 1998-11 · Application 1019980048780
- Subsidiary: 동아제약METHOD OF PREPARING SULFIDE DERIVATIVES
PCT · Published · 1998-11 · Application PCT/KR1998/000354
Expired · 1998-11 · Application 1020017005632
Rejected · 1998-10 · Application 1019980042961
Expired · 1998-08 · Application 1019980032997
Rejected · 1998-08 · Application 1019980032538
- Subsidiary: 동아제약Itraconazole with improved solubility, method of preparing same and pharmaceutical composition for oral administration comprising same
CN · Published · 1998-06 · Application 98806999
EP · Registered · 1998-06 · Application 98929878.1
PCT · Published · 1998-06 · Application PCT/KR1998/000164
Rejected · 1998-05 · Application 1019980018397
Expired · 1998-05 · Application 1019980016534
Expired · 1998-03 · Application 1019980008325
Withdrawn · 1998-02 · Application 1019980005938
Expired · 1998-02 · Application 1019980003137
Expired · 1997-12 · Application 1019970070873
Expired · 1997-09 · Application 1019970048854
- Subsidiary: 동아제약GASTROPROTECTIVE FLAVONE/FLAVANONE COMPOUNDS WITH THERAPEUTIC EFFECT ON INFLAMMATORY BOWEL DISEASE
EP · Registered · 1997-07 · Application 97932032.2
- Subsidiary: 동아제약GASTROPROTECTIVE FLAVONE/FLAVANONE COMPOUNDS WITH THERAPEUTIC EFFECT ON INFLAMMATORY BOWEL DISEASE
PCT · Published · 1997-07 · Application PCT/KR1997/000144
Expired · 1997-07 · Application 1019970033265
Expired · 1997-07 · Application 1019970033266
Withdrawn · 1997-06 · Application 1019970024938
Expired · 1997-06 · Application 1019970024939
Expired · 1997-06 · Application 1019970024662
Withdrawn · 1997-06 · Application 1019970024166
Expired · 1997-05 · Application 1019970021727
Expired · 1997-05 · Application 1019970021728
Expired · 1997-05 · Application 1019970020752
Expired · 1997-05 · Application 1019970020753
Expired · 1997-04 · Application 1019970012407
Expired · 1997-03 · Application 1019970009843
Expired · 1997-01 · Application 1019970000867
Withdrawn · 1996-12 · Application 1019960080851
Expired · 1996-10 · Application 1019960050681
Expired · 1996-10 · Application 1019960045669
Expired · 1996-10 · Application 1019960045162
Expired · 1996-07 · Application 1019960030494
Rejected · 1996-07 · Application 1019960029306
Expired · 1996-07 · Application 1019960028230
Rejected · 1996-06 · Application 1019960025606
Expired · 1996-06 · Application 1019960024758
Rejected · 1996-06 · Application 1019960023712
Rejected · 1996-06 · Application 1019960023711
Expired · 1996-04 · Application 2019960007822
Withdrawn · 1996-02 · Application 1019960002605
Withdrawn · 1996-02 · Application 1019960002606
Expired · 1995-12 · Application 1019950046413
Expired · 1995-11 · Application 1019950044287
Withdrawn · 1995-09 · Application 1019950031491
Withdrawn · 1995-09 · Application 1019950031490
Expired · 1995-09 · Application 1019950028755
Abandoned · 1995-08 · Application 1019950025974
Expired · 1995-08 · Application 1019950024813
Rejected · 1995-08 · Application 1019950023726
Expired · 1995-07 · Application 1019950023422
Rejected · 1995-07 · Application 1019950023424
Expired · 1995-07 · Application 1019950023423
Expired · 1995-07 · Application 1019950021957
Rejected · 1995-05 · Application 1019950014261
Rejected · 1995-05 · Application 1019950012160
Withdrawn · 1995-04 · Application 1019950008490
Expired · 1995-03 · Application 1019950005790
Withdrawn · 1994-10 · Application 1019940026206
Withdrawn · 1994-10 · Application 1019940026207
Expired · 1994-10 · Application 1019940025766
Expired · 1994-10 · Application 1019940025767
Expired · 1994-10 · Application 1019940025765
Withdrawn · 1994-10 · Application 1019940025546
Withdrawn · 1994-08 · Application 1019940021448
Expired · 1994-08 · Application 1019940021201
Withdrawn · 1994-08 · Application 1019940020971
Rejected · 1994-08 · Application 1019940019835
- Subsidiary: 동아제약CABAPENEM DERIVATIVES AND PROCESSES FOR PREPARING THE SAME
PCT · Published · 1994-05 · Application PCT/KR1994/000059
Expired · 1994-01 · Application 1019940000246
Rejected · 1993-11 · Application 1019930025002
Withdrawn · 1993-11 · Application 1019930024780
Withdrawn · 1993-11 · Application 1019930023763
Withdrawn · 1993-11 · Application 1019930023762
Withdrawn · 1993-10 · Application 1019930022051
Withdrawn · 1993-09 · Application 1019930020270
Withdrawn · 1993-09 · Application 1019950700834
Expired · 1993-07 · Application 1019930014480
US · Registered · 1993-06 · Application 08077952
Withdrawn · 1993-03 · Application 1019930003140
Rejected · 1992-12 · Application 1019920025359
Withdrawn · 1992-11 · Application 1019920021327
Expired · 1992-09 · Application 1019920017802
Withdrawn · 1992-09 · Application 1019920015910
Expired · 1992-06 · Application 1019920010859
Withdrawn · 1992-06 · Application 1019920009883
Rejected · 1992-04 · Application 1019920007188
Withdrawn · 1992-04 · Application 1019920005922
Expired · 1992-02 · Application 1019920002828
Rejected · 1992-02 · Application 1019920002827
Expired · 1992-02 · Application 1019920002829
Expired · 1991-12 · Application 1019910024764
Expired · 1991-11 · Application 1019910021360
Expired · 1991-07 · Application 1019920700744
Expired · 1991-02 · Application 1019910002652
Expired · 1990-10 · Application 1019900017084
Withdrawn · 1990-10 · Application 1019900016213
Expired · 1990-07 · Application 1019900010901
Expired · 1990-07 · Application 1019900010902
Expired · 1990-07 · Application 1019900010903
Rejected · 1990-06 · Application 1019900009017
Withdrawn · 1990-04 · Application 1019900005283
Expired · 1990-03 · Application 1019900003989
Rejected · 1990-03 · Application 1019900002857
Expired · 1989-11 · Application 1019890017506
Expired · 1989-10 · Application 1019890015375
Expired · 1989-08 · Application 1019890012050
Expired · 1989-08 · Application 1019890012049
Expired · 1989-06 · Application 1019890007730
Expired · 1988-12 · Application 1019880017120
Expired · 1988-10 · Application 1019880014046
Rejected · 1988-07 · Application 2019880011576
Expired · 1988-06 · Application 1019880007516
Expired · 1988-05 · Application 1019880005564
Expired · 1988-04 · Application 2019880005737
Rejected · 1988-03 · Application 1019880003407
Expired · 1988-02 · Application 1019880000943
Rejected · 1986-12 · Application 2019860020499
Expired · 1986-11 · Application 1019860009519
Withdrawn · 1986-08 · Application 1019860006682
Expired · 1986-07 · Application 1019860006056
Expired · 1986-05 · Application 1019860003778
Expired · 1986-05 · Application 1019860003777
Expired · 1986-05 · Application 2019860006135
Withdrawn · 1985-08 · Application 2019850010611
Rejected · 1985-04 · Application 2019850004099
Expired · 1984-12 · Application 2019840014558
Expired · 1984-06 · Application 1019840003325
Expired · 1984-04 · Application 1019840001858
Expired · 1983-12 · Application 2019830011495
Expired · 1983-12 · Application 1019830006297
Expired · 1983-12 · Application 1019830006229
Withdrawn · 1983-12 · Application 1019830006140
Withdrawn · 1983-12 · Application 1019830005892
Withdrawn · 1983-05 · Application 1019830002317
Withdrawn · 1982-12 · Application 1019820005780
Rejected · 1982-07 · Application 1019820003295
Expired · 1982-06 · Application 1019820002827
Expired · 1982-06 · Application 1019820002500
Expired · 1982-05 · Application 1019820001957
Rejected · 1982-02 · Application 1019820000802
Rejected · 1982-02 · Application 1019820000432
Rejected · 1982-01 · Application 1019820000030
Expired · 1981-12 · Application 1019810005264
Rejected · 1981-07 · Application 1019810002667
Expired · 1981-04 · Application 1019810001448
Expired · 1980-09 · Application 2019800006033
Expired · 1980-06 · Application 1019800002427
Withdrawn · 1980-06 · Application 1019800002302
Withdrawn · 1980-04 · Application 1019800001401
Withdrawn · 1980-02 · Application 1019800000829
Expired · 1980-01 · Application 1019800000171
Expired · 1979-10 · Application 1019790003757
Expired · 1979-10 · Application 1019790003456
Withdrawn · 1979-02 · Application 1019790000436
Expired · 1977-12 · Application 1019770003078
Expired · 1977-12 · Application 1019770002973
Expired · 1977-12 · Application 1019770002807
Expired · 1977-10 · Application 1019770002466
Expired · 1977-04 · Application 2019770002912
Expired · 1976-02 · Application 1019760000389
Expired · 1976-01 · Application 1019760000135
Expired · 1975-12 · Application 1019750002757
Expired · 1970-07 · Application 2019700003239
Expired · 1969-01 · Application 1019690000094
Expired · 1968-07 · Application 2019680002463
Expired · 1968-04 · Application 2019680001208
Expired · 1967-08 · Application 2019670002175
Expired · 1967-06 · Application 1019670000518
Expired · 1966-11 · Application 2019660002986
Expired · 1966-03 · Application 1019660000200
AI reads
MAA server logs · IP-verifiedPulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.
Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.
Collected as raw material for future answers.
Queries from users who connected this index to their own AI.
- OpenAIOAI-SearchBot61
- PerplexityPerplexityBot5
- AnthropicClaudeBot2
- GoogleGoogleOther1
Measured since Aug 27, 2026 · 4 AI engines · last read Oct 9, 2026
User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.
Connect this company index directly to your AI
Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for Dong-A Socio Holdings Co.,Ltd and every listed Korean medical, bio and AI company.
How to connect (MCP)Companies approved for the same productsMedical Devices
Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.
KOSDAQ-listed medical device company producing human tissue implants Bella Cell HD and SureFuse.
Dongwha Pharm, founded in 1897 and KOSPI-listed in 1976, is a diversified company centered on pharmaceuticals.
WonIk, founded in 1983 and KOSDAQ-listed in 1997, operates pressure sensor, dermo-cosmetic, and medical device distribution businesses.
GC Medical Science Corporation, KOSDAQ-listed since 2014, operates diagnostic reagent, blood glucose, and hemodialysis solution businesses.
KOSDAQ-listed medical device company producing PDRN pharmaceuticals, HA fillers, and Rejuran-branded cosmetics.
KOSDAQ-listed aesthetics and CMO company behind the Elravie/Revolax hyaluronic-acid fillers and Leedstox botulinum toxin.
Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.
Wonbiogen Co.,Ltd., established September 2018, listed on KOSDAQ in December 2018, manufactures wound dressings and moist wound dressings.
Founded and listed on KOSPI in 2012 upon spin-off from the former Kolmar Korea, KOLMAR KOREA runs cosmetics ODM, prescription drugs, and packaging.
Founded in 1945, JW Pharmaceutical holds an original drug pipeline including Rivalo and Hemlibra, plus the IV nutrition product Winuf and OTC brand Hwakol.
KOSDAQ-listed comprehensive healthcare and pharmaceutical company behind the gum treatment Insadol and the wound-care ointment Madecassol.
Founded in 2000 and listed on KOSDAQ in 2017, Keeps Biopharma transitioned from OLED equipment to pharmaceuticals through its 2025 merger with Korea Global Pharm.
Sources and updates
Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- Approvals & clinical trials
- Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
- Key disclosures
- KRX KIND via OpenDART exchange filings — updated daily
- Global clinical trials
- ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
- Financials
- DART corporate disclosure filings — annual
- Publications
- PubMed (US National Library of Medicine) — affiliation-matched, updated daily
- Patents
- KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
- AI reads
- Our server logs, IP-verified every 6 hours
- AI visibility
- Measured 2026-10-01
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition